Literature DB >> 11696012

Degradation of G(M1) and G(M2) by mammalian sialidases.

S C Li1, Y T Li, S Moriya, T Miyagi.   

Abstract

In mammalian tissues, the pathway known for the catabolism of G(M1) [Galbeta3GalNAcbeta4(Neu5Acalpha3)Galbeta4GlcCer; where Cer is ceramide] is the conversion of this ganglioside into G(M2) [GalNAcbeta4(Neu5Acalpha3)Galbeta4GlcbetaCer] by beta-galactosidase followed by the conversion of G(M2) into G(M3) (Neu5Acalpha3Galbeta4GlcbetaCer) by beta-N-acetylhexosaminidase A (Hex A). However, the question of whether or not G(M1) and G(M2) can also be respectively converted into asialo-G(M1) (Galbeta3GalNAcbeta4Galbeta4GlcCer; G(A1)) and asialo-G(M2) (GalNAcbeta4Galbeta4GlcbetaCer, G(A2)) by mammalian sialidases has not been resolved. This is due to the fact that sialidases purified from mammalian tissues always contained detergents that interfered with the in vitro hydrolysis of G(M1) and G(M2) in the presence of an activator protein. The mouse model of human type B Tay-Sachs disease created by the disruption of the Hexa gene showed no neurological abnormalities, with milder clinical symptoms than the human counterpart, and the accumulation of G(M2) in the brains of affected mice was only limited to certain regions [Sango, Yamanaka, Hoffmann, Okuda, Grinberg, Westphal, McDonald, Crawley, Sandhoff, Suzuki and Proia (1995) Nat. Genet. 11, 170-176]. These results suggest the possible presence of an alternative catabolic pathway (the G(A2) pathway) in mouse to convert G(M2) into G(A2) by sialidase. To show the existence of this pathway, we have used recombinant mammalian cytosolic sialidase and membrane-associated sialidase to study the desialylation of G(M1) and G(M2). We found that the mouse membrane-bound sialidase was able to convert G(M1) and G(M2) into their respective asialo-derivatives in the presence of human or mouse G(M2) activator protein. The cytosolic sialidase did not exhibit this activity. Our results suggest that, in vivo, the stable NeuAc of G(M1) and G(M2) may be removed by the mammalian membrane-associated sialidase in the presence of G(M2) activator protein. They also support the presence of the G(A2) pathway for the catabolism of G(M2) in mouse.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11696012      PMCID: PMC1222222          DOI: 10.1042/0264-6021:3600233

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  29 in total

1.  Diphenylamine-aniline-phosphoric acid reagent, a versatile spray reagent for revealing glycoconjugates on thin-layer chromatography plates.

Authors:  K Anderson; S C Li; Y T Li
Journal:  Anal Biochem       Date:  2000-12-15       Impact factor: 3.365

2.  Crystal structure of human GM2-activator protein with a novel beta-cup topology.

Authors:  C S Wright; S C Li; F Rastinejad
Journal:  J Mol Biol       Date:  2000-12-01       Impact factor: 5.469

3.  Neuraminidase activity in mammalian organs.

Authors:  R CARUBELLI; R E TRUCCO; R CAPUTTO
Journal:  Biochim Biophys Acta       Date:  1962-06-18

4.  Fluorometric assay of neuraminidase with a sodium (4-methylumbelliferyl-alpha-D-N-acetylneuraminate) substrate.

Authors:  M Potier; L Mameli; M Bélisle; L Dallaire; S B Melançon
Journal:  Anal Biochem       Date:  1979-04-15       Impact factor: 3.365

5.  Cloning, expression and chromosomal mapping of human lysosomal sialidase and characterization of mutations in sialidosis.

Authors:  A V Pshezhetsky; C Richard; L Michaud; S Igdoura; S Wang; M A Elsliger; J Qu; D Leclerc; R Gravel; L Dallaire; M Potier
Journal:  Nat Genet       Date:  1997-03       Impact factor: 38.330

6.  Characterization of human lysosomal neuraminidase defines the molecular basis of the metabolic storage disorder sialidosis.

Authors:  E Bonten; A van der Spoel; M Fornerod; G Grosveld; A d'Azzo
Journal:  Genes Dev       Date:  1996-12-15       Impact factor: 11.361

7.  Identification of a sialidase encoded in the human major histocompatibility complex.

Authors:  C M Milner; S V Smith; M B Carrillo; G L Taylor; M Hollinshead; R D Campbell
Journal:  J Biol Chem       Date:  1997-02-14       Impact factor: 5.157

8.  Mouse models of Tay-Sachs and Sandhoff diseases differ in neurologic phenotype and ganglioside metabolism.

Authors:  K Sango; S Yamanaka; A Hoffmann; Y Okuda; A Grinberg; H Westphal; M P McDonald; J N Crawley; K Sandhoff; K Suzuki; R L Proia
Journal:  Nat Genet       Date:  1995-10       Impact factor: 38.330

9.  Rat-liver lysosomal sialidase. Solubilization, substrate specificity and comparison with the cytosolic sialidase.

Authors:  T Miyagi; S Tsuiki
Journal:  Eur J Biochem       Date:  1984-05-15

10.  Molecular cloning of mouse ganglioside sialidase and its increased expression in Neuro2a cell differentiation.

Authors:  T Hasegawa; K Yamaguchi; T Wada; A Takeda; Y Itoyama; T Miyagi
Journal:  J Biol Chem       Date:  2000-03-17       Impact factor: 5.157

View more
  7 in total

1.  Attenuated pulmonary fibrosis in sialidase-3 knockout (Neu3-/-) mice.

Authors:  Tejas R Karhadkar; Wensheng Chen; Richard H Gomer
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-10-16       Impact factor: 5.464

2.  Synthesis of reference standards to enable single cell metabolomic studies of tetramethylrhodamine-labeled ganglioside GM1.

Authors:  E Andreas Larsson; Ulf Olsson; Colin D Whitmore; Rita Martins; Guido Tettamanti; Ronald L Schnaar; Norman J Dovichi; Monica M Palcic; Ole Hindsgaul
Journal:  Carbohydr Res       Date:  2006-10-07       Impact factor: 2.104

Review 3.  Pathology and current treatment of neurodegenerative sphingolipidoses.

Authors:  Matthias Eckhardt
Journal:  Neuromolecular Med       Date:  2010-08-22       Impact factor: 3.843

Review 4.  Recent development in mammalian sialidase molecular biology.

Authors:  Eugenio Monti; Augusto Preti; Bruno Venerando; Giuseppe Borsani
Journal:  Neurochem Res       Date:  2002-08       Impact factor: 3.996

Review 5.  Sialidase NEU3 and its pathological significance.

Authors:  Taeko Miyagi; Koji Yamamoto
Journal:  Glycoconj J       Date:  2022-06-08       Impact factor: 3.009

6.  Comparative analysis of brain lipids in mice, cats, and humans with Sandhoff disease.

Authors:  Rena C Baek; Douglas R Martin; Nancy R Cox; Thomas N Seyfried
Journal:  Lipids       Date:  2008-11-26       Impact factor: 1.880

Review 7.  Keeping it trim: roles of neuraminidases in CNS function.

Authors:  Alexey V Pshezhetsky; Mila Ashmarina
Journal:  Glycoconj J       Date:  2018-08-07       Impact factor: 2.916

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.